Some patients, particularly those with neurological involvement, may benefit from more frequent dosing (every 2 months rather than 3 months), but this should be medically supervised rather than self-adjusted
Another rare risk is hypokalemia (low potassium), with symptoms like muscle weakness and irregular heartbeat, which can occur when treatment begins for severe anemia
But theres no data showing how well it works in humans, and the long-term safety of this peptide in humans is simply unknown
Follow these steps for every opened vial: Record the first puncture date and time on the vial label immediately after opening, using a permanent marker
Molecular Formula : CHN Molecular Weight : 159.21 g/mol PubChem CID : 950107 CAS Number : 42464-96-0 Synonyms : 5-amino-1-methylquinolinium Source: PubChem In controlled laboratory settings, 5-Amino-1MQ may be used to investigate how NNMT modulation affects NAD+ availability, redox balance, and related metabolic pathways
As for medical use, BPC-157 may only be used for research purposes with special permission (as in the two pilot studies mentioned above) and may not be sold to the public or even prescribed by medical doctors, according to the U.S